subject: CHEMBL.COMPOUND:CHEMBL1743073

subject_name: SOTATERCEPT


subject: UMLS:C2699571

subject_name: sotatercept

object_name: Solid Neoplasm

tested_intervention: unsure


subject: UMLS:C5784712

subject_name: Anti-CLDN18.2 Monoclonal Antibody ZL-1211

object_name: Advanced Malignant Solid Neoplasm

tested_intervention: yes


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: septic shock


subject: CHEBI:8228

object_name: Severe Sepsis


subject: UMLS:C5963458

subject_name: Protease-activated Interferon Alpha-2b Prodrug CX-801

object_name: Adult Solid Neoplasm


subject: UMLS:C1508862

subject_name: INJECTION, BEVACIZUMAB, 10 MG, Administered

object_name: Pneumonia caused by SARS-CoV-2


subject: UMLS:C2729368

subject_name: INJECTION, BEVACIZUMAB, 0.25 MG, Administered


subject: UMLS:C5203354

subject_name: Bevacizumab Liquid Injection


subject: CHEBI:3219

subject_name: Bupropion

object_name: Tobacco user


subject: CHEBI:3219

object_name: Tobacco use history


subject: CHEBI:3219

object_name: Encounter due to tobacco use


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: skin squamous cell carcinoma


subject: CHEBI:94518

object_name: cutaneous squamous cell carcinoma


subject: CHEBI:233453

object_name: bipolar disorder


subject: CHEBI:35854

subject_name: Valaciclovir


subject: UNII:21P2M98388

subject_name: Henagliflozin

object_name: Weight loss


subject: UNII:21P2M98388

object_name: Weight Loss, CTCAE


subject: UNII:21P2M98388

object_name: Prediabetes


subject: UNII:2AD53WQ2CX

object_name: Poisoning by, adverse effect of and underdosing of oral contraceptives


subject: UNII:2AD53WQ2CX

object_name: Poisoning by oral contraceptive


subject: UNII:2AD53WQ2CX

object_name: Oral contraceptives causing adverse effects in therapeutic use


subject: PUBCHEM.COMPOUND:135260636

object_name: Alzheimer disease type 1


subject: PUBCHEM.COMPOUND:135260636

object_name: Alzheimer disease


subject: MESH:C478920

object_name: rheumatoid arthritis


subject: UNII:832O37V7MZ

subject_name: Nacubactam

object_name: Complicated intra-abdominal infection


subject: UNII:832O37V7MZ

object_name: Complicated urinary tract infection


subject: UNII:832O37V7MZ

object_name: VABP


subject: UNII:832O37V7MZ

object_name: acute pyelonephritis


subject: UMLS:C5139691

subject_name: nacubactam


subject: UMLS:C5139691


subject: UMLS:C5139691


subject: UMLS:C5139691


subject: CHEBI:9605

subject_name: Tirofiban

object_name: occlusion; vessel


subject: UNII:6E01CG547T

subject_name: MITOQUINONE MESYLATE

object_name: hepatitis C


subject: UNII:6E01CG547T

object_name: chronic hepatitis C virus infection


subject: UMLS:C5690695

subject_name: mitoquinone mesylate


subject: UMLS:C5690695


subject: UMLS:C5690696

subject_name: MitoQ


subject: UMLS:C5690696


subject: RXCUI:8375

subject_name: placebo Oral Tablet

object_name: temporomandibular joint disorder


subject: UNII:0125DUV5XC

subject_name: varlilumab

object_name: B-cell neoplasm


subject: UMLS:C3274549


subject: CHEBI:79033

subject_name: florbetaben F18

object_name: familial amyloid neuropathy


subject: CHEBI:79033

object_name: ATTR Amyloidosis


subject: PUBCHEM.COMPOUND:2684

subject_name: cevimeline

object_name: Xerostomia


subject: PUBCHEM.COMPOUND:2684

object_name: Dry Mouth, CTCAE


subject: CHEBI:9654

subject_name: Trazodone

object_name: Blood Pressure Finding


subject: CHEBI:9654

object_name: Systemic arterial pressure


subject: CHEBI:9654

object_name: hypertension


subject: CHEBI:9654

object_name: Chronic Insomnia


subject: UMLS:C4287766

object_name: prostate carcinoma


subject: UMLS:C4287766

object_name: prostate cancer


subject: UMLS:C4287766

object_name: metastatic prostate carcinoma


subject: UMLS:C4287766

object_name: castration-resistant prostate carcinoma


subject: CHEBI:33325

subject_name: radium atom

object_name: bone disorder


subject: CHEBI:33325

object_name: neoplasm


subject: UMLS:C3827153


subject: UMLS:C3827153


subject: CHEBI:45863

subject_name: Paclitaxel


subject: UMLS:C2830069

subject_name: Smoothened Antagonist LDE225

object_name: carcinoma of esophagus


subject: UMLS:C2830069

object_name: esophageal cancer


subject: UMLS:C2830069

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C2830069

object_name: neoplasm of esophagus


subject: CHEBI:90863

subject_name: Sonidegib


subject: CHEBI:90863


subject: CHEBI:90863


subject: CHEBI:90863


subject: UMLS:C0031237

subject_name: pertussis vaccine

object_name: Rheumatism


subject: DRUGBANK:DB10989

subject_name: Hepatitis A Vaccine


subject: UMLS:C0170300

subject_name: Hepatitis A Vaccines


subject: GTOPDB:12990

subject_name: sintilimab

object_name: Carcinoma breast stage IV


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: CHEBI:135744

subject_name: Fenoverine

object_name: irritable bowel syndrome


subject: GTOPDB:13582

object_name: cystic fibrosis


subject: GTOPDB:13582

object_name: Persistent Infection


subject: UMLS:C3540792

subject_name: Magnesium supplements, alimentary tract and metabolism

object_name: Postoperative Pain, Acute


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:18420


subject: UMLS:C3714621

subject_name: Magnesium Drug Class


subject: CHEBI:7454

subject_name: Nalbuphine


subject: UMLS:C4708608

subject_name: Technetium diethylenetriamine pentaacetic acid

object_name: lung carcinoma


subject: UMLS:C4708608

object_name: Primary malignant neoplasm


subject: UMLS:C4708608

object_name: cancer


subject: UMLS:C4708608

object_name: childhood malignant neoplasm


subject: UMLS:C4708608

object_name: Malignant obstetric neoplasm


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:31822

subject_name: MERCAPTOPURINE


subject: CHEBI:31822

object_name: acute myeloid leukemia


subject: CHEBI:2208

subject_name: Mercaptopurine


subject: CHEBI:2208


subject: CHEBI:45716

subject_name: Vorinostat

object_name: acute leukemia of ambiguous lineage


subject: CHEBI:50733

subject_name: nutraceutical

object_name: alcoholic hepatitis


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: Insulin Sensitivity


subject: UMLS:C0919075

subject_name: INJECTION, ZIDOVUDINE, 10 MG ADMINISTERED

object_name: chronic kidney disease


subject: UMLS:C0919075

object_name: Chronic uremia


subject: CHEBI:10110

subject_name: Zidovudine


subject: CHEBI:10110


subject: CHEBI:50949

subject_name: serotonin uptake inhibitor

object_name: mal de Debarquement


subject: CHEBI:50949

object_name: Minimal Disseminated Disease


subject: UMLS:C0360105

subject_name: Selective Serotonin Reuptake Inhibitors


subject: UMLS:C0360105


subject: UMLS:C2911696

subject_name: Serotonin Reuptake Inhibitor [EPC]


subject: UMLS:C2911696


subject: CHEBI:35176

subject_name: Zinc sulfate

object_name: endogenous depression


subject: CHEBI:35176

object_name: major depressive disorder


subject: CHEBI:35176


subject: CHEBI:35176


subject: CHEBI:9150

subject_name: Simvastatin

object_name: heart disorder


subject: CHEBI:46936

subject_name: Nonivamide

object_name: Low back pain


subject: CHEBI:32322

subject_name: Nicoboxil


subject: PR:000005953

subject_name: chondroitin sulfate proteoglycan 4

object_name: melanoma


subject: PR:000014139

subject_name: E3 ubiquitin-protein ligase RNF5


subject: CHEBI:38940

subject_name: Sunitinib

object_name: leiomyosarcoma of the corpus uteri


subject: CHEBI:38940

object_name: Recurrent Uterine Sarcoma


subject: CHEBI:42797

subject_name: Gabapentin

object_name: Pendular nystagmus


subject: CHEBI:64312

subject_name: Memantine


subject: CHEBI:6931

subject_name: Midazolam

object_name: invasive aspergillosis


subject: CHEBI:93363

subject_name: Naphazoline

object_name: ocular hyperemia


subject: CHEBI:231614

subject_name: Nivolumab

object_name: IMMUNE SUPPRESSION


subject: UMLS:C2346820


subject: CHEBI:87681

subject_name: Ranolazine

object_name: end stage renal failure


subject: CHEBI:87681


subject: CHEBI:87681

object_name: cardiovascular disorder


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Sepsis


subject: CHEBI:46195

object_name: Sepsis, CTCAE


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: CHEBI:132922


subject: CHEBI:132922


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:33380

subject_name: thulium atom

object_name: Deficiency of anterior cruciate ligament


subject: CHEBI:19226


subject: CHEBI:74861

subject_name: Thr-Met


subject: CHEBI:55460

subject_name: trimellityl group


subject: CHEBI:30703

subject_name: Tetrathiomolybdate


subject: UMLS:C3166394

subject_name: Tm antigen


subject: PR:000002105

subject_name: thrombomodulin


subject: CHEBI:150712

subject_name: Hyaluronic acid


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEBI:135915

subject_name: Thymalfasin

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C5417816

subject_name: c-Met Inhibitor ABN401

object_name: neoplasm


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Adult Hodgkin Lymphoma


subject: CHEBI:63791

object_name: Childhood Hodgkin Lymphoma


subject: CHEBI:669

object_name: chronic kidney disease


subject: CHEBI:669

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:184492


subject: CHEBI:184492


subject: CHEBI:30216

subject_name: alpha-particle


subject: CHEBI:30216


subject: UMLS:C5400714

subject_name: ALPHA (substance)


subject: UMLS:C5400714


subject: UNII:AC10C1L8VO

subject_name: alpha


subject: UNII:AC10C1L8VO


subject: PR:000001067

subject_name: transient receptor potential cation channel TRPV1 isoform 1


subject: PR:000001067


subject: CHEBI:30212

subject_name: photon


subject: CHEBI:30212


subject: CHEBI:10545

subject_name: electron


subject: CHEBI:27013

subject_name: Tocopherol


subject: CHEBI:27013


subject: CHEBI:30314

subject_name: Lipoic acid


subject: CHEBI:30314


subject: CHEBI:43796

subject_name: (S)-lipoic acid


subject: CHEBI:43796


subject: CHEBI:16494

subject_name: thioctic acid


subject: CHEBI:16494


subject: CHEBI:134512

object_name: Medication interaction potentiation


subject: CHEBI:2469

subject_name: Adefovir


subject: CHEBI:47426

subject_name: Furosemide


subject: CHEBI:28911

subject_name: cob(III)alamin

object_name: psychosis


subject: CHEBI:28911

object_name: Nonorganic psychosis


subject: CHEBI:28911

object_name: Psychosis, CTCAE


subject: PUBCHEM.COMPOUND:165339223

subject_name: Vitamin B 12


subject: PUBCHEM.COMPOUND:165339223


subject: PUBCHEM.COMPOUND:165339223


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: HMDB:HMDB0000607


subject: HMDB:HMDB0000607


subject: CHEBI:176843

subject_name: vitamin B12


subject: CHEBI:176843


subject: CHEBI:176843


subject: UMLS:C0086024

subject_name: cobalamins


subject: UMLS:C0086024


subject: UMLS:C0086024


subject: CHEBI:17439


subject: CHEBI:17439


subject: CHEBI:17439


subject: UMLS:C2936883

subject_name: Vitamin B12 [EPC]


subject: UMLS:C2936883


subject: UMLS:C2936883


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEBI:25681


subject: CHEBI:25681


subject: CHEBI:7421

subject_name: NAC


subject: CHEBI:7421


subject: CHEBI:7421


subject: CHEBI:6339

subject_name: Etoricoxib

object_name: Headache


subject: CHEBI:6339

object_name: Headache, CTCAE


subject: UNII:N5UK68MGDZ

subject_name: Apremilast

object_name: alopecia areata


subject: UNII:N5UK68MGDZ

object_name: alopecia


subject: CHEBI:149504

object_name: stroke disorder


subject: CHEBI:149504

object_name: cerebrovascular disorder


subject: CHEBI:149504

object_name: Stroke (heart beat)


subject: CHEBI:149504

object_name: Stroke, CTCAE


subject: CHEBI:149504

object_name: Blood Pressure Finding


subject: CHEBI:149504

object_name: Systemic arterial pressure


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:5778

subject_name: Hydrochlorothiazide


subject: CHEBI:5778


subject: CHEBI:5778


subject: CHEBI:9241

subject_name: Spironolactone


subject: CHEBI:9241


subject: CHEBI:9241


subject: CHEBI:9241


subject: CHEBI:9241


subject: CHEBI:9241


subject: UMLS:C4705708

object_name: chronic rhinosinusitis with nasal polyps


subject: CHEBI:231614

subject_name: Nivolumab

object_name: germ cell tumor


subject: UMLS:C2346820


subject: CHEBI:94534

subject_name: olanzapine

object_name: Terminal illness


subject: CHEBI:32599

object_name: atrial fibrillation new onset


subject: CHEBI:32599

object_name: Critical Illness


subject: PUBCHEM.COMPOUND:135402009

object_name: Asperger syndrome


subject: CHEBI:15640


subject: CHEBI:63606


subject: UMLS:C5854662

subject_name: PEG-PEI-cholesterol Lipopolymer-encased IL-12 DNA Plasmid Vector IMNN-001

object_name: Primary Peritoneal Cancer


subject: CHEBI:10033

subject_name: Warfarin

object_name: unspecified adult solid tumor, protocol specific


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UNII:4EQZ6YO2HI

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UNII:4EQZ6YO2HI

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UNII:4EQZ6YO2HI

object_name: HER2/Neu Negative


subject: UNII:4EQZ6YO2HI

object_name: Metastatic Breast Carcinoma in the Bone


subject: UNII:4EQZ6YO2HI

object_name: Estrogen Receptor Positive


subject: UNII:4EQZ6YO2HI

object_name: Progesterone Receptor Positive


subject: UMLS:C1530450

subject_name: AMG 162


subject: UMLS:C1530450


subject: UMLS:C1530450


subject: UMLS:C1530450


subject: UMLS:C1530450


subject: UMLS:C1530450


subject: UMLS:C1530450


subject: CHEBI:3374

subject_name: Capsaicin

object_name: Hyperalgesia, Primary


subject: GTOPDB:13792

subject_name: iparomlimab

object_name: carcinoma of esophagus


subject: GTOPDB:13792

object_name: esophageal cancer


subject: GTOPDB:13792

object_name: Childhood Esophageal Carcinoma


subject: GTOPDB:13792

object_name: neoplasm of esophagus


subject: UNII:FN3VWV28BC

subject_name: IPAROMLIMAB


subject: UNII:FN3VWV28BC


subject: UNII:FN3VWV28BC


subject: UNII:FN3VWV28BC


subject: UMLS:C5669553

subject_name: Iparomlimab


subject: UMLS:C5669553


subject: UMLS:C5669553


subject: UMLS:C5669553


subject: UNII:PSQ4R5K1QI

object_name: chronic hepatitis C virus infection


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: cervical intraepithelial neoplasia grade 2/3


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: UNII:SE2KH7T06F

object_name: pediatric osteosarcoma


subject: UNII:SE2KH7T06F

object_name: Osteosarcoma


subject: UNII:SE2KH7T06F

object_name: Osteosarcoma recurrent


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: PUBCHEM.COMPOUND:21634109

subject_name: Lacosamide

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:36088

subject_name: thromboxanes A

object_name: cancer


subject: CHEBI:36088

object_name: neoplasm


subject: CHEBI:36088

object_name: Surgical procedure finding


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: angioid streaks


subject: PR:000014685

subject_name: plasma serine protease inhibitor

object_name: coronary artery disorder


subject: PR:000014685

object_name: coronary atherosclerosis


subject: UMLS:C5555587

subject_name: Anti-c-Met/MMAE ADC RC108

object_name: Childhood Solid Neoplasm


subject: UMLS:C5555587

object_name: Adult Solid Neoplasm


subject: UMLS:C5555587

object_name: Solid Neoplasm


subject: CHEBI:139072

object_name: Poisoning by, adverse effect of and underdosing of other psychotropic drugs


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:7773

subject_name: Ondansetron

object_name: acute respiratory distress syndrome


subject: CHEBI:7773

object_name: adult acute respiratory distress syndrome


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: tumor suppressor gene on chromosome 11


subject: UMLS:C4053601


subject: CHEBI:93829

subject_name: Ifenprodil

object_name: multiple sclerosis


subject: CHEBI:93829

object_name: relapsing-remitting multiple sclerosis


subject: UMLS:C4725753

subject_name: Vudalimab

object_name: colorectal cancer


subject: UMLS:C4725753

object_name: colorectal carcinoma


subject: UMLS:C4725753

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C4725753

object_name: colon carcinoma


subject: UMLS:C4725753

object_name: colon cancer


subject: UMLS:C4725753

object_name: rectal carcinoma


subject: UMLS:C4725753

object_name: rectal cancer


subject: CHEBI:36333

subject_name: local anaesthetic

object_name: Femoroacetabular impingement


subject: UMLS:C3536836

subject_name: Local Anesthetic [EPC]


subject: CHEBI:15365

subject_name: Aspirin

object_name: Lynch syndrome I (site-specific colonic cancer)


subject: UMLS:C5222496

subject_name: Repository Corticotropin Injection

object_name: sarcoidosis


subject: UMLS:C5222496

object_name: sarcoidosis, susceptibility to, 1


subject: CHEBI:5001

subject_name: Fenofibrate

object_name: spinal cord injury


subject: CHEBI:36704

subject_name: Imiquimod

object_name: Oral Epithelial Dysplasia


subject: CHEBI:36704

object_name: Leukokeratosis


subject: CHEBI:36704

object_name: leukoplakia


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]

object_name: carcinoma of esophagus


subject: UMLS:C5848866

object_name: esophageal cancer


subject: UMLS:C5848866

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C5848866

object_name: neoplasm of esophagus


subject: UMLS:C5848866

object_name: gastroesophageal cancer


subject: CHEBI:87631

subject_name: statin

object_name: heart failure


subject: CHEBI:87631

object_name: Heart Failure, CTCAE


subject: CHEBI:87631

object_name: Arrhythmia


subject: CHEBI:87631

object_name: Acute pulmonary edema


subject: UMLS:C0007220

subject_name: Cardiovascular Agents

object_name: acute coronary syndrome


subject: UMLS:C0007220


subject: UMLS:C0007220


subject: UMLS:C0007220


subject: UMLS:C0007220


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Recurrence


subject: PUBCHEM.COMPOUND:14907381

object_name: Recurrent Malignant Neoplasm


subject: PUBCHEM.COMPOUND:14907381

object_name: Recurrent disease


subject: PUBCHEM.COMPOUND:14907381

object_name: Recurrent tumor


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:8768

subject_name: Rabeprazole

object_name: insomnia


subject: CHEBI:8768

object_name: Insomnia, CTCAE 3.0


subject: CHEBI:8768

object_name: Insomnia, CTCAE 5.0


subject: CHEBI:41423

subject_name: Celecoxib

object_name: malignant pleural mesothelioma


subject: CHEBI:95165


subject: CHEBI:95165

object_name: non-small cell lung carcinoma


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:61080

subject_name: Romidepsin


subject: CHEBI:61080


subject: UMLS:C4082795

subject_name: Depsipeptide Antineoplastic Antibiotic


subject: UMLS:C4082795


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0796678

subject_name: Depsipeptides


subject: UMLS:C0796678


subject: GTOPDB:12990

subject_name: sintilimab

object_name: Advanced lung cancer


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: CHEBI:184555

subject_name: Xylan Sulfate

object_name: lower urinary tract symptom


subject: CHEBI:184555

object_name: urinary bladder carcinoma


subject: CHEBI:135004

subject_name: Nefiracetam

object_name: Alzheimer disease


subject: PUBCHEM.COMPOUND:73995022

subject_name: Casein

object_name: phenylketonuria


subject: DRUGBANK:DB10516


subject: UMLS:C0007332

subject_name: caseins


subject: CHEBI:6128

subject_name: Ketoprofen

object_name: pneumothorax


subject: CHEBI:6128

object_name: Pneumothorax, CTCAE


subject: UMLS:C0700737


subject: UMLS:C0700737


subject: UMLS:C4053664

object_name: adrenal cortex carcinoma


subject: UMLS:C4053664

object_name: adenoid cystic carcinoma


subject: UMLS:C4727017

subject_name: TetMYB DNA Vaccine


subject: UMLS:C4727017


subject: UMLS:C4727017

object_name: colorectal cancer


subject: UMLS:C4727017

object_name: colorectal carcinoma


subject: UMLS:C4727017

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:109549

subject_name: Ramelteon

object_name: Transient disorder of initiating or maintaining sleep


subject: CHEBI:109549

object_name: Transient Insomnia


subject: UMLS:C1828874

subject_name: GlipiZIDE XL

object_name: hyperglycemia


subject: UMLS:C1828874

object_name: Hyperglycemia, CTCAE


subject: UMLS:C1828874

object_name: Glucose in blood specimen above reference range


subject: UMLS:C1828874

object_name: type 2 diabetes mellitus


subject: UMLS:C1828874

object_name: maturity-onset diabetes of the young type 1


subject: PUBCHEM.COMPOUND:44573417

subject_name: METFORMIN XR


subject: PUBCHEM.COMPOUND:44573417


subject: PUBCHEM.COMPOUND:44573417


subject: PUBCHEM.COMPOUND:44573417


subject: PUBCHEM.COMPOUND:3043660


subject: PUBCHEM.COMPOUND:3043660


subject: PUBCHEM.COMPOUND:3043660


subject: PUBCHEM.COMPOUND:3043660


subject: CHEBI:71272

subject_name: Saxagliptin


subject: CHEBI:71272


subject: CHEBI:71272


subject: CHEBI:53785

subject_name: alverine citrate

object_name: portal hypertension


subject: CHEBI:53785

object_name: Portal Hypertension, CTCAE


subject: CHEBI:518413

subject_name: Alverine


subject: UNII:03J11K103C

subject_name: ALGELDRATE

object_name: type 1 diabetes mellitus 1


subject: UNII:03J11K103C

object_name: type 1 diabetes mellitus


subject: GTOPDB:13716

subject_name: disitamab vedotin

object_name: Carcinoma breast stage IV


subject: GTOPDB:13716

object_name: Advanced breast cancer


subject: GTOPDB:13716

object_name: triple-negative breast carcinoma


subject: GTOPDB:13716

object_name: breast neoplasm


subject: GTOPDB:13716

object_name: gastric neoplasm


subject: UNII:RB3U3A1S27

subject_name: DISITAMAB VEDOTIN


subject: UNII:RB3U3A1S27


subject: UNII:RB3U3A1S27


subject: UNII:RB3U3A1S27


subject: UNII:RB3U3A1S27


subject: UMLS:C4329329


subject: UMLS:C4329329


subject: UMLS:C4329329


subject: UMLS:C4329329


subject: UMLS:C4329329


subject: UNII:234248D0HH

subject_name: Tucatinib

object_name: Malignant neoplasm of stomach stage IV


subject: UNII:234248D0HH


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: hypertension


subject: CHEBI:6888

object_name: Hypertension, CTCAE


subject: CHEBI:6888

object_name: Blood Pressure Finding


subject: CHEBI:6888

object_name: Systemic arterial pressure


subject: CHEBI:6888

object_name: heart failure


subject: CHEBI:6888

object_name: Heart Failure, CTCAE


subject: MESH:D006495

subject_name: Heparin, Low-Molecular-Weight

object_name: abortion


subject: MESH:D006495

object_name: Pregnancy loss


subject: MESH:D006495

object_name: Pregnancy Loss, CTCAE


subject: UMLS:C3536766

subject_name: Low Molecular Weight Heparin [EPC]


subject: UMLS:C3536766


subject: UMLS:C3536766


subject: CHEBI:135735

subject_name: Delapril

object_name: type 2 diabetes mellitus


subject: UMLS:C0591841

subject_name: Nalcrom

object_name: dyspepsia


subject: UMLS:C0591841

object_name: Dyspepsia, CTCAE


subject: CHEBI:59773

subject_name: CROMOLYN


subject: CHEBI:59773


subject: UNII:3ZY6J6Z6EE

subject_name: Droxidopa

object_name: neurally mediated hypotension


subject: UNII:3ZY6J6Z6EE

object_name: myalgic encephalomeyelitis/chronic fatigue syndrome


subject: PUBCHEM.COMPOUND:3080587

subject_name: Megestrol

object_name: malignant mesothelioma


subject: UNII:43K1W2T1M6

subject_name: Interferon alfa-2b

object_name: Influenza A virus infection


subject: CHEBI:41001

subject_name: Benzoylecgonine


subject: PUBCHEM.COMPOUND:251912

subject_name: Benzoyl ecgonine


subject: UMLS:C2698319

subject_name: Bacillus Calmette-Guerin Antigen


subject: PR:000002994

subject_name: natural resistance-associated macrophage protein 1


subject: CHEBI:31355

subject_name: Carboplatin

object_name: malignant neoplasm of breast stage IV


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid

object_name: ovarian neoplasm


subject: CHEBI:231005

object_name: BRCA1 gene mutation


subject: CHEBI:231005

object_name: BRCA2 gene mutation


subject: CHEBI:63587

subject_name: Eribulin


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:62880

subject_name: Veliparib


subject: PUBCHEM.COMPOUND:129887057

object_name: Parkinson disease


subject: UNII:K6396E6G8G


subject: UNII:7P55415B0R


subject: UNII:F3HG38I0T1

subject_name: IMVOTAMAB

object_name: rheumatoid arthritis


subject: UNII:F3HG38I0T1

object_name: arthritis


subject: UNII:F3HG38I0T1

object_name: Arthritis, CTCAE


subject: UMLS:C5236954

subject_name: Imvotamab


subject: UMLS:C5236954


subject: UMLS:C5236954


subject: UMLS:C5853470

object_name: achromatopsia


subject: UMLS:C1832030

object_name: primary brain neoplasm


subject: CHEBI:2637

subject_name: Amikacin

object_name: appendicitis


subject: CHEBI:2637

object_name: Appendicitis, CTCAE


subject: CHEBI:2637

object_name: Surgical procedure finding


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: Eosinophilic disorder


subject: CHEBI:66919

object_name: Eosinophilia


subject: CHEBI:66919

object_name: Eosinophilia, CTCAE


subject: CHEBI:66919

object_name: chronic eosinophilic leukemia


subject: CHEBI:66919

object_name: Blasts 20 Percent or Less of Peripheral Blood White Cells


subject: CHEBI:66919

object_name: Blasts More Than 5 Percent of Peripheral Blood White Cells


subject: CHEBI:66919

object_name: Blasts More than 5 Percent of Bone Marrow Nucleated Cells


subject: CHEBI:66919

object_name: Blasts Under 20 Percent of Bone Marrow Nucleated Cells


subject: CHEBI:66919

object_name: BCR-JAK2 Fusion Protein Expression


subject: CHEBI:66919

object_name: ETV6-JAK2 Fusion Protein Expression


subject: CHEBI:66919

object_name: JAK2 Gene Mutation


subject: CHEBI:66919

object_name: Hepatomegaly


subject: HMDB:HMDB0032337

subject_name: Hydroxypropyl cellulose

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: HMDB:HMDB0032337

object_name: amyotrophic lateral sclerosis


subject: CHEBI:6931

subject_name: Midazolam

object_name: Acute pulmonary edema


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: Stage IVA Uterine Sarcoma AJCC v7


subject: CHEBI:79699

object_name: Stage IVB Uterine Sarcoma AJCC v7


subject: CHEBI:79699

object_name: Recurrent Uterine Corpus Sarcoma


subject: CHEBI:79699

object_name: sarcoma of uterus stage IIIb


subject: CHEBI:79699

object_name: Stage IIIB Uterine Sarcoma AJCC v7


subject: CHEBI:79699

object_name: Stage IIIC Uterine Sarcoma AJCC v7


subject: GTOPDB:8414

subject_name: trebananib

object_name: lung carcinoid tumor


subject: GTOPDB:8414

object_name: Renal cell carcinoma recurrent


subject: GTOPDB:8414

object_name: Stage IV Renal Cell Cancer


subject: GTOPDB:8414

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: GTOPDB:8414

object_name: Stage III Renal Cell Cancer AJCC v8


subject: GTOPDB:8414

object_name: Stage III renal cell cancer


subject: GTOPDB:8414


subject: GTOPDB:8414


subject: GTOPDB:8414


subject: GTOPDB:8414


subject: GTOPDB:8414


subject: GTOPDB:8414


subject: GTOPDB:8414

object_name: Recurrent Digestive System Neuroendocrine Tumor G1


subject: GTOPDB:8414

object_name: Adult Solid Neoplasm


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UMLS:C1541521

subject_name: AMG 386


subject: UMLS:C1541521


subject: UMLS:C1541521


subject: UMLS:C1541521


subject: UMLS:C1541521


subject: UMLS:C1541521


subject: UMLS:C1541521


subject: UMLS:C1541521


subject: UMLS:C1541521


subject: UMLS:C1541521


subject: UMLS:C1541521


subject: UMLS:C1541521


subject: UMLS:C1541521


subject: UMLS:C1541521


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Refractory Rectal Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Recurrent Rectal Cancer


subject: PUBCHEM.COMPOUND:2767

object_name: Recurrent Sarcoma


subject: PUBCHEM.COMPOUND:2767

object_name: Refractory Sarcoma


subject: PUBCHEM.COMPOUND:2767

object_name: Refractory Rhabdomyosarcoma


subject: PUBCHEM.COMPOUND:2767

object_name: Refractory Liposarcoma


subject: PUBCHEM.COMPOUND:2767

object_name: Resectable Liposarcoma


subject: PUBCHEM.COMPOUND:2767

object_name: Refractory Primary Peritoneal Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Recurrent Childhood Rhabdomyosarcoma


subject: PUBCHEM.COMPOUND:2767

object_name: Recurrent Rhabdomyosarcoma


subject: PUBCHEM.COMPOUND:2767

object_name: Liposarcoma recurrent


subject: PUBCHEM.COMPOUND:2767

object_name: Refractory Ovarian Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Refractory Gastric Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Refractory Colon Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Malignant Abdominal Neoplasm


subject: PUBCHEM.COMPOUND:2767

object_name: Colon cancer recurrent


subject: PUBCHEM.COMPOUND:2767

object_name: Refractory Fallopian Tube Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Resectable Malignant Mesothelioma


subject: PUBCHEM.COMPOUND:2767

object_name: Refractory Malignant Mesothelioma


subject: PUBCHEM.COMPOUND:2767

object_name: Refractory Desmoplastic Small Round Cell Tumor


subject: PUBCHEM.COMPOUND:2767

object_name: Recurrent Desmoplastic Small Round Cell Tumor


subject: PUBCHEM.COMPOUND:2767

object_name: Pelvic Cancer


subject: CHEBI:64816

object_name: Refractory Rectal Carcinoma


subject: CHEBI:64816

object_name: Recurrent Rectal Cancer


subject: CHEBI:64816

object_name: Refractory Sarcoma


subject: CHEBI:64816

object_name: Refractory Rhabdomyosarcoma


subject: CHEBI:64816

object_name: Refractory Liposarcoma


subject: CHEBI:64816

object_name: Resectable Liposarcoma


subject: CHEBI:64816

object_name: Refractory Primary Peritoneal Carcinoma


subject: CHEBI:64816

object_name: Recurrent Childhood Rhabdomyosarcoma


subject: CHEBI:64816

object_name: Recurrent Rhabdomyosarcoma


subject: CHEBI:64816

object_name: Recurrent Primary Peritoneal Carcinoma


subject: CHEBI:64816

object_name: Liposarcoma recurrent


subject: CHEBI:64816

object_name: Refractory Ovarian Carcinoma


subject: CHEBI:64816

object_name: Refractory Gastric Carcinoma


subject: CHEBI:64816

object_name: Refractory Colon Carcinoma


subject: CHEBI:64816

object_name: Malignant Abdominal Neoplasm


subject: CHEBI:64816

object_name: recurrent gastric cancer


subject: CHEBI:64816

object_name: Colon cancer recurrent


subject: CHEBI:64816

object_name: Refractory Fallopian Tube Carcinoma


subject: CHEBI:64816

object_name: Resectable Malignant Mesothelioma


subject: CHEBI:64816

object_name: Refractory Malignant Mesothelioma


subject: CHEBI:64816

object_name: Refractory Desmoplastic Small Round Cell Tumor


subject: CHEBI:64816

object_name: Recurrent Desmoplastic Small Round Cell Tumor


subject: CHEBI:64816

object_name: Mesothelioma malignant recurrent


subject: CHEBI:64816

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:64816

object_name: Pelvic Cancer


subject: CHEBI:91872

object_name: Refractory Rectal Carcinoma


subject: CHEBI:91872

object_name: Recurrent Rectal Cancer


subject: CHEBI:91872

object_name: Refractory Sarcoma


subject: CHEBI:91872

object_name: Refractory Rhabdomyosarcoma


subject: CHEBI:91872

object_name: Refractory Liposarcoma


subject: CHEBI:91872

object_name: Resectable Liposarcoma


subject: CHEBI:91872

object_name: Refractory Primary Peritoneal Carcinoma


subject: CHEBI:91872

object_name: Recurrent Rhabdomyosarcoma


subject: CHEBI:91872

object_name: Recurrent Primary Peritoneal Carcinoma


subject: CHEBI:91872

object_name: Liposarcoma recurrent


subject: CHEBI:91872

object_name: Refractory Ovarian Carcinoma


subject: CHEBI:91872

object_name: Refractory Gastric Carcinoma


subject: CHEBI:91872

object_name: Refractory Colon Carcinoma


subject: CHEBI:91872

object_name: Malignant Abdominal Neoplasm


subject: CHEBI:91872

object_name: recurrent gastric cancer


subject: CHEBI:91872

object_name: Colon cancer recurrent


subject: CHEBI:91872

object_name: Refractory Fallopian Tube Carcinoma


subject: CHEBI:91872

object_name: Resectable Malignant Mesothelioma


subject: CHEBI:91872

object_name: Refractory Malignant Mesothelioma


subject: CHEBI:91872

object_name: Refractory Desmoplastic Small Round Cell Tumor


subject: CHEBI:91872

object_name: Recurrent Desmoplastic Small Round Cell Tumor


subject: CHEBI:91872

object_name: Mesothelioma malignant recurrent


subject: CHEBI:91872

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:91872

object_name: Pelvic Cancer


subject: CHEBI:28748

subject_name: Doxorubicin

object_name: Refractory Rectal Carcinoma


subject: CHEBI:28748

object_name: Recurrent Rectal Cancer


subject: CHEBI:28748

object_name: Refractory Sarcoma


subject: CHEBI:28748

object_name: Refractory Rhabdomyosarcoma


subject: CHEBI:28748

object_name: Refractory Liposarcoma


subject: CHEBI:28748

object_name: Resectable Liposarcoma


subject: CHEBI:28748

object_name: Refractory Primary Peritoneal Carcinoma


subject: CHEBI:28748

object_name: Recurrent Rhabdomyosarcoma


subject: CHEBI:28748

object_name: Liposarcoma recurrent


subject: CHEBI:28748

object_name: Refractory Ovarian Carcinoma


subject: CHEBI:28748

object_name: Refractory Gastric Carcinoma


subject: CHEBI:28748

object_name: Refractory Colon Carcinoma


subject: CHEBI:28748

object_name: Malignant Abdominal Neoplasm


subject: CHEBI:28748

object_name: recurrent gastric cancer


subject: CHEBI:28748

object_name: Colon cancer recurrent


subject: CHEBI:28748

object_name: Refractory Fallopian Tube Carcinoma


subject: CHEBI:28748

object_name: Resectable Malignant Mesothelioma


subject: CHEBI:28748

object_name: Refractory Malignant Mesothelioma


subject: CHEBI:28748

object_name: Refractory Desmoplastic Small Round Cell Tumor


subject: CHEBI:28748

object_name: Recurrent Desmoplastic Small Round Cell Tumor


subject: CHEBI:28748

object_name: Mesothelioma malignant recurrent


subject: CHEBI:28748

object_name: Pelvic Cancer


subject: CHEBI:32150

object_name: Refractory Rectal Carcinoma


subject: CHEBI:32150

object_name: Recurrent Rectal Cancer


subject: CHEBI:32150

object_name: Recurrent Sarcoma


subject: CHEBI:32150

object_name: Resectable Sarcoma


subject: CHEBI:32150

object_name: Refractory Sarcoma


subject: CHEBI:32150

object_name: Refractory Rhabdomyosarcoma


subject: CHEBI:32150

object_name: Refractory Liposarcoma


subject: CHEBI:32150

object_name: Resectable Liposarcoma


subject: CHEBI:32150

object_name: Refractory Primary Peritoneal Carcinoma


subject: CHEBI:32150

object_name: Recurrent Childhood Rhabdomyosarcoma


subject: CHEBI:32150

object_name: Recurrent Rhabdomyosarcoma


subject: CHEBI:32150

object_name: Recurrent Primary Peritoneal Carcinoma


subject: CHEBI:32150

object_name: Liposarcoma recurrent


subject: CHEBI:32150

object_name: Refractory Ovarian Carcinoma


subject: CHEBI:32150

object_name: Refractory Gastric Carcinoma


subject: CHEBI:32150

object_name: Refractory Colon Carcinoma


subject: CHEBI:32150

object_name: Recurrent ovarian cancer


subject: CHEBI:32150

object_name: Malignant Abdominal Neoplasm


subject: CHEBI:32150

object_name: recurrent gastric cancer


subject: CHEBI:32150

object_name: Colon cancer recurrent


subject: CHEBI:32150

object_name: Refractory Fallopian Tube Carcinoma


subject: CHEBI:32150

object_name: Resectable Malignant Mesothelioma


subject: CHEBI:32150

object_name: Refractory Malignant Mesothelioma


subject: CHEBI:32150

object_name: Refractory Desmoplastic Small Round Cell Tumor


subject: CHEBI:32150

object_name: Recurrent Desmoplastic Small Round Cell Tumor


subject: CHEBI:32150

object_name: Mesothelioma malignant recurrent


subject: CHEBI:32150

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:32150

object_name: Pelvic Cancer


subject: CHEBI:132112

object_name: Refractory Rectal Carcinoma


subject: CHEBI:132112

object_name: Recurrent Rectal Cancer


subject: CHEBI:132112

object_name: Recurrent Sarcoma


subject: CHEBI:132112

object_name: Resectable Sarcoma


subject: CHEBI:132112

object_name: Refractory Sarcoma


subject: CHEBI:132112

object_name: Refractory Rhabdomyosarcoma


subject: CHEBI:132112

object_name: Refractory Liposarcoma


subject: CHEBI:132112

object_name: Resectable Liposarcoma


subject: CHEBI:132112

object_name: Refractory Primary Peritoneal Carcinoma


subject: CHEBI:132112

object_name: Recurrent Childhood Rhabdomyosarcoma


subject: CHEBI:132112

object_name: Recurrent Rhabdomyosarcoma


subject: CHEBI:132112

object_name: Recurrent Primary Peritoneal Carcinoma


subject: CHEBI:132112

object_name: Liposarcoma recurrent


subject: CHEBI:132112

object_name: Refractory Ovarian Carcinoma


subject: CHEBI:132112

object_name: Refractory Gastric Carcinoma


subject: CHEBI:132112

object_name: Refractory Colon Carcinoma


subject: CHEBI:132112

object_name: Recurrent ovarian cancer


subject: CHEBI:132112

object_name: Malignant Abdominal Neoplasm


subject: CHEBI:132112

object_name: recurrent gastric cancer


subject: CHEBI:132112

object_name: Colon cancer recurrent


subject: CHEBI:132112

object_name: Refractory Fallopian Tube Carcinoma


subject: CHEBI:132112

object_name: Resectable Malignant Mesothelioma


subject: CHEBI:132112

object_name: Refractory Malignant Mesothelioma


subject: CHEBI:132112

object_name: Refractory Desmoplastic Small Round Cell Tumor


subject: CHEBI:132112

object_name: Recurrent Desmoplastic Small Round Cell Tumor


subject: CHEBI:132112

object_name: Mesothelioma malignant recurrent


subject: CHEBI:132112

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:132112

object_name: Pelvic Cancer


subject: UMLS:C5201260

object_name: psoriasis


subject: UMLS:C4519110

subject_name: Fletikumab


subject: CHEBI:33704

subject_name: Amino acid

object_name: arteriosclerosis disorder


subject: CHEBI:33704

object_name: atherosclerosis


subject: CHEBI:33704

object_name: disease (or disorder); serum


subject: PUBCHEM.COMPOUND:169449957

subject_name: Amino Acids


subject: PUBCHEM.COMPOUND:169449957


subject: PUBCHEM.COMPOUND:169449957


subject: CHEMBL.COMPOUND:CHEMBL1201498

subject_name: AMINO ACIDS


subject: CHEMBL.COMPOUND:CHEMBL1201498


subject: CHEMBL.COMPOUND:CHEMBL1201498


subject: UMLS:C3539946

subject_name: Amino Acids, I.V. solution additive


subject: UMLS:C3539946


subject: UMLS:C3539946


subject: UMLS:C0002520


subject: UMLS:C0002520


subject: UMLS:C0002520


subject: UMLS:C3539947

subject_name: Antifibrinolytic amino acids


subject: UMLS:C3539947


subject: UMLS:C3539947


subject: CHEBI:36233

subject_name: disaccharide


subject: CHEBI:36233


subject: CHEBI:36233


subject: GTOPDB:4977

object_name: acute myeloid leukemia by FAB classification


subject: GTOPDB:4977

object_name: acute myeloid leukemia


subject: UMLS:C0123759


subject: UMLS:C0123759


subject: UMLS:C1328728


subject: UMLS:C1328728


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: psoriasis vulgaris


subject: UMLS:C3152625

subject_name: Pneumococcal 13-valent conjugate vaccine

object_name: type 1 diabetes mellitus 1


subject: UMLS:C3152625

object_name: type 1 diabetes mellitus


subject: UMLS:C5815614

subject_name: BAX 888

object_name: hemophilia A


subject: DRUGBANK:DB17850


subject: UMLS:C2348288

subject_name: Dietary Zinc

object_name: Insulin resistance


subject: UMLS:C2348288

object_name: Pediatric Obesity


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:29105


subject: CHEBI:27363

subject_name: Zinc


subject: CHEBI:27363


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: UMLS:C3714650


subject: CHEBI:24848

subject_name: inositol

object_name: Zinc deficiency


subject: CHEBI:24848


subject: UNII:5491FXS1NB

subject_name: Mesokain

object_name: inflammatory bowel disease


subject: CHEBI:135013

subject_name: trimecaine


subject: UMLS:C0795762

subject_name: Mesocaine


subject: CHEBI:91529


subject: PUBCHEM.COMPOUND:287691

subject_name: Thiocolchicoside


subject: CHEBI:2666

subject_name: Amitriptyline


subject: UNII:V5PC588N7G

subject_name: Mag 2 (TN)


subject: CHEBI:16010


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: Atypical lobular hyperplasia


subject: CHEBI:66919

object_name: atypical lobular breast hyperplasia


subject: CHEBI:66919

object_name: lobular breast carcinoma in situ


subject: CHEBI:66919

object_name: lobular neoplasia


subject: CHEBI:66919

object_name: atypical ductal hyperplasia


subject: CHEBI:66919

object_name: ductal breast carcinoma in situ


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Skin squamous cell carcinoma metastatic


subject: CHEBI:231679

object_name: Carcinoma Metastatic to the Skin


subject: CHEBI:231679

object_name: Unresectable Skin Squamous Cell Carcinoma


subject: CHEBI:231679

object_name: Unresectable Basal Cell Carcinoma


subject: CHEBI:231679

object_name: Unresectable Merkel Cell Carcinoma


subject: CHEBI:231679

object_name: Metastatic basal cell carcinoma


subject: CHEBI:231679

object_name: Metastatic Merkel cell carcinoma


subject: CHEBI:231679

object_name: Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8


subject: CHEBI:231679

object_name: Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:8382

subject_name: Prednisone

object_name: Unresectable Melanoma


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:9168

object_name: metastatic melanoma


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:9168

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:9168

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:9168


subject: CHEBI:9168


subject: GTOPDB:8268

subject_name: veltuzumab

object_name: non-Hodgkin lymphoma


subject: GTOPDB:8268

object_name: diffuse large B-cell lymphoma


subject: GTOPDB:8268

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: GTOPDB:8268

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: GTOPDB:8268

object_name: lymphoma, non-Hodgkin, familial


subject: GTOPDB:8268

object_name: Lymphoma, Large-Cell, Follicular


subject: UNII:BPD4DGQ314


subject: UNII:BPD4DGQ314


subject: UNII:BPD4DGQ314


subject: UNII:BPD4DGQ314


subject: UNII:BPD4DGQ314


subject: UNII:BPD4DGQ314


subject: UMLS:C1529789


subject: UMLS:C1529789


subject: UMLS:C1529789


subject: UMLS:C1529789


subject: UMLS:C1529789


subject: UMLS:C1529789


subject: CHEBI:6067

subject_name: Isotretinoin

object_name: juvenile myelomonocytic leukemia


subject: PUBCHEM.COMPOUND:108169

subject_name: Taxane


subject: PUBCHEM.COMPOUND:108169


subject: UMLS:C0796419

subject_name: Taxanes


subject: UMLS:C0796419


subject: UMLS:C0304497

subject_name: Cytotoxic agent (product)


subject: UMLS:C0304497


subject: UMLS:C1135138


subject: UMLS:C1135138


subject: PUBCHEM.COMPOUND:3417

object_name: Prosthetic joint infection


subject: CHEBI:62247


subject: CHEBI:62419


subject: CHEBI:28915

subject_name: Fosfomycin


subject: UMLS:C3661268

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C3661268

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UMLS:C3661268

object_name: acute lymphoblastic leukemia


subject: UMLS:C3661268

object_name: acute myeloid leukemia


subject: UMLS:C3661268

object_name: Myelodysplasia


subject: UMLS:C3661268

object_name: Myelodysplasia, CTCAE


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-


subject: PUBCHEM.COMPOUND:1805


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Glomerular vascular disorder


subject: CHEBI:6888

object_name: Glomerulopathy


subject: CHEBI:8382


subject: CHEBI:8382


subject: UNII:WTT295HSY5

subject_name: Dulaglutide

object_name: hyperglycemia


subject: UMLS:C2976495


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: colorectal adenocarcinoma


subject: UMLS:C5417984

subject_name: MEK Inhibitor HL-085

object_name: non-small cell lung carcinoma


subject: CHEBI:233453

object_name: neoplasm


subject: CHEBI:35854

subject_name: Valaciclovir


subject: PUBCHEM.COMPOUND:156857753

object_name: tuberculosis


subject: CHEBI:9014

subject_name: Salsalate

object_name: anemia


subject: CHEBI:9014

object_name: Anemia, CTCAE


subject: CHEBI:25357

subject_name: mitomycin

object_name: biliary tract cancer


subject: CHEBI:27504

subject_name: Mitomycin


subject: CHEBI:5779

subject_name: Hydrocodone

object_name: primary interstitial lung disease specific to childhood


subject: CHEBI:5779

object_name: interstitial lung disease specific to childhood


subject: CHEBI:5779

object_name: Laceration


subject: CHEBI:46195

subject_name: Acetaminophen


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: CHEBI:59064

subject_name: colistin A

object_name: ventilator-associated pneumonia


subject: CHEBI:194186

subject_name: Tirzepatide

object_name: schizophrenia


subject: CHEBI:194186

object_name: Schizophrenia Spectrum and Other Psychotic Disorders


subject: CHEBI:71219

subject_name: Pazopanib

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: proteinuria


subject: CHEBI:39548

object_name: Proteinuria of undiagnosed cause


subject: CHEBI:39548

object_name: Proteinuria, CTCAE 3.0


subject: CHEBI:39548

object_name: Proteinuria, CTCAE 5.0


subject: UMLS:C1138626

subject_name: cocoa extract

object_name: peripheral vascular disease


subject: UMLS:C1138626

object_name: peripheral arterial disease


subject: DRUGBANK:DB10977

subject_name: Cocoa


subject: DRUGBANK:DB10977


subject: PR:000004970

subject_name: calcium-binding and coiled-coil domain-containing protein 1


subject: PR:000004970


subject: UMLS:C0939909

subject_name: Theobroma cacao, cocoa, chocolate


subject: UMLS:C0939909


subject: UMLS:C5418011

subject_name: CSF-1R Inhibitor ABSK021

object_name: tenosynovial giant cell tumor


subject: UMLS:C5418011

object_name: tenosynovial giant cell tumor, diffuse type


subject: UMLS:C5418011

object_name: neoplasm


subject: CHEBI:188153

subject_name: Oteseconazole

object_name: tinea unguium


subject: CHEBI:8874

subject_name: Rivastigmine

object_name: methamphetamine dependence


subject: CHEBI:8874

object_name: Harmful pattern of use of methamphetamine


subject: CHEBI:8874

object_name: Harmful pattern of substance use


subject: CHEBI:8874

object_name: substance abuse


subject: GTOPDB:12347

subject_name: penpulimab

object_name: pancreatic neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297571

subject_name: PENPULIMAB


subject: UMLS:C4723695


subject: UMLS:C1527130

object_name: HIV infection


subject: UMLS:C1527130

object_name: Cytopenia


subject: UMLS:C0021757


subject: UMLS:C0021757


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS

object_name: adult acute respiratory distress syndrome


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEBI:229274

subject_name: Nicotinamide riboside chloride

object_name: ulcerative colitis


subject: CHEBI:229274

object_name: inflammatory bowel disease 1


subject: UMLS:C4476285

subject_name: Nicotinamide Riboside Chloride


subject: UMLS:C4476285


subject: CHEBI:231087

subject_name: Trilaciclib


subject: CHEBI:231087

object_name: exocrine pancreatic carcinoma


subject: CHEBI:231087

object_name: malignant pancreatic neoplasm


subject: CHEBI:49960

subject_name: Vandetanib

object_name: paraganglioma


subject: CHEBI:49960

object_name: adrenal gland pheochromocytoma


subject: CHEBI:49960

object_name: pheochromocytoma


subject: CHEBI:32139

object_name: type 2 diabetes mellitus


subject: CHEBI:32139

object_name: Dysglycemia


subject: CHEBI:50841

subject_name: Loxapine

object_name: Agitation


subject: CHEBI:50841

object_name: respiratory failure


subject: CHEBI:50841

object_name: bronchopulmonary dysplasia


subject: CHEBI:50841

object_name: Respiratory insufficiency


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: nail disorder


subject: CHEBI:5855

subject_name: Ibuprofen


subject: UNII:6897GXD6OE

object_name: Anemia of pregnancy


subject: UNII:3M6325NY1R

subject_name: Iron isomaltoside 1000


subject: UNII:PTC2969MV1

subject_name: Halofuginone Hydrobromide

object_name: Kaposi Sarcoma


subject: UNII:PTC2969MV1

object_name: Recurrent Kaposi Sarcoma


subject: UMLS:C0521922

subject_name: Halofuginone hydrobromide


subject: UMLS:C0521922


subject: CHEBI:3077

subject_name: Betamethasone

object_name: Greater trochanteric pain syndrome


subject: CHEBI:92998

subject_name: Guanabenz

object_name: chronic kidney disease


subject: CHEBI:92998

object_name: Chronic Kidney Disease, CTCAE


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: Refractory acute myeloid leukemia


subject: UNII:4Z63YK6E0E

object_name: High Risk Myelodysplastic Syndrome


subject: UNII:4Z63YK6E0E

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:3077

object_name: Neck pain


subject: CHEBI:3077

object_name: Neck Pain, CTCAE 5.0


subject: CHEBI:3077

object_name: Neck Pain, CTCAE 3.0


subject: CHEBI:3077

object_name: Back Pain, CTCAE 5.0


subject: CHEBI:3077

object_name: Back pain


subject: CHEBI:3077

object_name: Back Pain, CTCAE 3.0


subject: CHEBI:31932

subject_name: olmesartan

object_name: inherited lipid metabolism disorder


subject: CHEBI:144094

subject_name: bicalutamide

object_name: Breast neoplasm female


subject: CHEBI:231679

subject_name: ipilimumab

object_name: breast neoplasm


subject: CHEBI:231679


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: CHEBI:74705

subject_name: Met-Leu

object_name: hypogonadism, male


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: PUBCHEM.COMPOUND:71455937

object_name: kidney failure


subject: CHEMBL.COMPOUND:CHEMBL4297744


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: Bronchopulmonary Dysplasia, AE


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: UNII:C137DTR5RG

subject_name: THEOPHYLLINE

object_name: contrast-induced nephropathy


subject: CHEBI:28177

subject_name: Theophylline


subject: UMLS:C0006404

subject_name: Subutex

object_name: HIV infection


subject: CHEBI:59585

object_name: prostate cancer


subject: CHEBI:59585

object_name: prostate neoplasm


subject: CHEBI:59585


subject: CHEBI:59585

object_name: plasma cell myeloma


subject: CHEBI:59585

object_name: Lytic lesion


subject: UMLS:C0162357

subject_name: Clodronate


subject: UMLS:C0162357


subject: UMLS:C0162357


subject: UMLS:C0162357


subject: UMLS:C0162357


subject: CHEBI:110423

subject_name: Clodronic acid


subject: CHEBI:110423


subject: CHEBI:110423


subject: CHEBI:110423


subject: CHEBI:110423


subject: UMLS:C0282130

subject_name: Bonefos


subject: UMLS:C0282130


subject: UMLS:C0282130


subject: UMLS:C0282130


subject: UMLS:C0282130


subject: MESH:D004043

subject_name: Dietary Fiber

object_name: liver neoplasm


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin


subject: UNII:NQX9KB6PCL

object_name: Fatigue, CTCAE 5.0


subject: UNII:NQX9KB6PCL

object_name: Fatigue


subject: UNII:NQX9KB6PCL

object_name: Cognitive impairment


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C0169964


subject: UMLS:C0169964


subject: UMLS:C0169964


subject: DRUGBANK:DB10647

subject_name: Parsley

object_name: cancer


subject: DRUGBANK:DB10647

object_name: neoplasm


subject: UMLS:C0994494

subject_name: parsley extract


subject: UMLS:C0994494


subject: UMLS:C4289970

subject_name: Anti-PD1 Monoclonal Antibody

object_name: melanoma


subject: PUBCHEM.COMPOUND:44450050

subject_name: Peptide 4


subject: CHEMBL.COMPOUND:CHEMBL2109092

subject_name: EPOETIN BETA

object_name: end stage renal failure


subject: CHEMBL.COMPOUND:CHEMBL2109092

object_name: chronic kidney disease


subject: CHEBI:92223

subject_name: Abexinostat

object_name: adult lymphoma


subject: CHEBI:92223

object_name: lymphoma


subject: CHEBI:92223

object_name: pediatric lymphoma


subject: CHEBI:92223

object_name: non-Hodgkin lymphoma


subject: CHEBI:92223


subject: CHEBI:92223

object_name: Hodgkin Disease


subject: CHEBI:92223

object_name: leukemia


subject: CHEBI:92223

object_name: childhood leukemia


subject: UMLS:C2003604


subject: UMLS:C2003604


subject: UMLS:C2003604


subject: UMLS:C2003604


subject: UMLS:C2003604

object_name: plasma cell myeloma


subject: UMLS:C2003604


subject: UMLS:C2003604


subject: UMLS:C2003604


subject: UMLS:C5238055

subject_name: Tengonermin

object_name: ovarian cancer


subject: UMLS:C5238055

object_name: ovarian neoplasm


subject: UMLS:C5238055

object_name: ovarian carcinoma


subject: UMLS:C1143119

subject_name: Zafiride


subject: UMLS:C1143119


subject: UMLS:C1143119


subject: CHEBI:17045

subject_name: Nitrous oxide

object_name: Labor Pain


subject: CHEBI:176724

subject_name: Etiracetam

object_name: generalized anxiety disorder


subject: CHEBI:176724

object_name: social phobia


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: UNII:73HC18Y1LW


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:6437


subject: CHEBI:149504

object_name: lupus nephritis


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:47426

subject_name: Furosemide

object_name: dehydration (Na, H2O)


subject: CHEBI:47426

object_name: Dehydration, CTCAE


subject: CHEBI:47426

object_name: Dehydration


subject: CHEBI:47426

object_name: brain edema


subject: UMLS:C3541937

subject_name: Azadirachta indica whole extract

object_name: Post-Operative Pain


subject: UMLS:C3541937

object_name: Postoperative Complications


subject: UMLS:C3541937

object_name: necrosis


subject: UMLS:C3541937

object_name: Necrotic Area Imaging Finding


subject: UMLS:C3541937

object_name: Necrotic Change


subject: UMLS:C3541937

object_name: Skin Necrosis


subject: UMLS:C3541937

object_name: Pathologic Processes


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog

object_name: retinal vein occlusion


subject: PUBCHEM.COMPOUND:18526330

subject_name: Glycyrrhetin

object_name: apparent mineralocorticoid excess


subject: PUBCHEM.COMPOUND:3230

subject_name: Biosone


subject: CHEBI:30853

subject_name: Enoxolone


subject: UNII:I60W9520VV

subject_name: Vadadustat

object_name: chronic kidney disease


subject: UNII:I60W9520VV

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:90225

subject_name: Rubitecan

object_name: Stomach cancer


subject: CHEBI:90225

object_name: gastric cancer


subject: CHEBI:90225

object_name: carcinoma of esophagus


subject: CHEBI:90225

object_name: esophageal cancer


subject: CHEBI:90225

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:90225

object_name: neoplasm of esophagus


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Intubation complication


subject: CHEBI:4466

object_name: Anaesthesia intubation complication


subject: CHEBI:4466

object_name: Tachycardia by ECG Finding


subject: CHEBI:4466

object_name: Tachycardia


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: CHEBI:36791

subject_name: Escitalopram

object_name: polydactyly-myopia syndrome


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:132922

object_name: Immune System and Related Disorders


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:95021

subject_name: pemetrexed

object_name: nasopharyngeal neoplasm


subject: CHEBI:63724


subject: GTOPDB:1160

subject_name: hCG

object_name: Androgen excess


subject: CHEBI:81570

subject_name: Chorionic Gonadotropin (Human)


subject: UMLS:C1141639

subject_name: human chorionic gonadotropin


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: HIV infection


subject: UMLS:C1099192


subject: CHEBI:63598

subject_name: Levofloxacin

object_name: pulmonary sarcoidosis


subject: CHEBI:4877

subject_name: Ethambutol


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: UNII:NV6352Y6TV

object_name: cardiovascular disorder


subject: CHEBI:6931

subject_name: Midazolam


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: POEMS syndrome


subject: CHEBI:188719

subject_name: Ertugliflozin

object_name: mitral valve insufficiency


subject: CHEBI:188719

object_name: Left Ventricular Systolic Dysfunction, CTCAE 3.0


subject: CHEBI:188719

object_name: Left Ventricular Systolic Dysfunction, CTCAE 5.0


subject: CHEBI:188719

object_name: Left ventricular systolic dysfunction


subject: UNII:I284LJY110

subject_name: Radotinib

object_name: bone marrow disorder


subject: CHEBI:27470

subject_name: Folic acid

object_name: coronary microvascular disorder


subject: CHEBI:28911

subject_name: cob(III)alamin


subject: CHEBI:28911


subject: PUBCHEM.COMPOUND:165339223

subject_name: Vitamin B 12


subject: PUBCHEM.COMPOUND:165339223


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: HMDB:HMDB0000607


subject: CHEBI:176843

subject_name: vitamin B12


subject: CHEBI:176843


subject: UMLS:C0086024

subject_name: cobalamins


subject: UMLS:C0086024


subject: CHEBI:17439


subject: CHEBI:17439


subject: UMLS:C2936883

subject_name: Vitamin B12 [EPC]


subject: UMLS:C2936883


subject: CHEBI:7959

subject_name: Penicillamine

object_name: scleroderma


subject: CHEBI:7959

object_name: systemic sclerosis


subject: UMLS:C0025536

subject_name: Metalcaptase


subject: UMLS:C0025536


subject: UMLS:C3714633

subject_name: Penicillamine Drug Class


subject: UMLS:C3714633


subject: UMLS:C0534628

subject_name: Endostatins

object_name: malignant tumor of nasopharynx


subject: UMLS:C1705207

subject_name: Endostar


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: Mania, CTCAE


subject: CHEBI:6887

object_name: Mania


subject: UMLS:C5854532

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5854532

object_name: Childhood Breast Carcinoma


subject: UMLS:C5854532

object_name: breast carcinoma


subject: UMLS:C5854532

object_name: breast cancer


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma


subject: UMLS:C0879636

subject_name: IMC C225


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: Neck Squamous Cell Carcinoma of Unknown Primary


subject: CHEBI:79699

object_name: Recurrent Neck Squamous Cell Carcinoma of Unknown Primary


subject: CHEBI:79699

object_name: Laryngeal squamous cell carcinoma recurrent


subject: CHEBI:79699

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: CHEBI:79699

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:79699

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:79699

object_name: Recurrent Salivary Gland Cancer


subject: CHEBI:79699

object_name: Laryngeal verrucous carcinoma recurrent


subject: CHEBI:79699

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: CHEBI:79699


subject: CHEBI:79699

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: CHEBI:79699

object_name: salivary gland squamous cell carcinoma


subject: CHEBI:79699

object_name: Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:79699

object_name: Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:79699

object_name: Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:79699

object_name: Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:79699

object_name: Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:79699

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:79699

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:79699

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:79699

object_name: Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:79699

object_name: Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7


subject: CHEBI:79699

object_name: Stage IVB Sinonasal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:79699

object_name: Stage IVC Sinonasal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:79699

object_name: Stage IVA Sinonasal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:79699

object_name: Stage IVA Oral Cavity Verrucous Carcinoma


subject: CHEBI:79699

object_name: Stage IVC Oral Cavity Verrucous Carcinoma


subject: CHEBI:79699

object_name: Stage IVB Oral Cavity Verrucous Carcinoma


subject: CHEBI:79699

object_name: Stage IVC Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:79699

object_name: Stage IVA Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:79699

object_name: Stage IVB Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:79699

object_name: Stage IVB Major Salivary Gland Cancer AJCC v7


subject: CHEBI:79699

object_name: Stage IVA Major Salivary Gland Cancer AJCC v7


subject: CHEBI:79699

object_name: Stage IVC Major Salivary Gland Cancer AJCC v7


subject: CHEBI:79699

object_name: tongue cancer


subject: CHEBI:79699

object_name: tongue carcinoma


subject: UMLS:C1541801

subject_name: TroVax

object_name: renal cell carcinoma


subject: UMLS:C5940911


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Stage II Prostate Cancer AJCC v6


subject: CHEBI:4672

object_name: Stage II Prostate Cancer AJCC v8


subject: CHEBI:4672

object_name: Carcinoma of the prostate stage II


subject: CHEBI:4672

object_name: Stage II Prostate Cancer AJCC v7


subject: CHEBI:4672

object_name: Stage I Prostate Cancer AJCC v6


subject: CHEBI:4672

object_name: Prostate cancer stage I


subject: CHEBI:4672

object_name: Stage I Prostate Cancer AJCC v8


subject: CHEBI:4672

object_name: Stage I Prostate Cancer AJCC v7


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: UMLS:C5574906

subject_name: Epidermal growth factor receptor inhibitor

object_name: adenoid cystic carcinoma


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: Cystic fibrosis related diabetes


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Headache


subject: CHEBI:73604

object_name: Headache, CTCAE


subject: PUBCHEM.COMPOUND:21149572

object_name: Frontal balding


subject: UMLS:C5815593

object_name: glaucoma


subject: UMLS:C5815593

object_name: Glaucoma, CTCAE


subject: UMLS:C5780032

subject_name: HUMAN CILIARY NEUROTROPHIC FACTOR


subject: UMLS:C5780032


subject: CHEBI:231679

subject_name: ipilimumab

object_name: skin squamous cell carcinoma


subject: CHEBI:231679

object_name: cutaneous squamous cell carcinoma


subject: PR:000001683

subject_name: vasopressin V2 receptor

object_name: Electrolyte imbalance


subject: PR:000001683

object_name: Hyponatremia


subject: PR:000001683

object_name: Hyponatremia, CTCAE


subject: PR:000001683

object_name: Hypernatremia


subject: PR:000001683

object_name: Hypernatremia, CTCAE


subject: CHEBI:4893

subject_name: ethyl acetoacetate

object_name: sarcopenia


subject: UMLS:C0243046

subject_name: Excitatory Amino Acids


subject: UMLS:C1527137

subject_name: Recombinant melatonin


subject: CHEBI:16796

subject_name: Melatonin


subject: UNII:D07V79Q44T

object_name: graft versus host disease


subject: UMLS:C1566164


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: spinal cord injury


subject: CHEBI:23359

subject_name: colchicine

object_name: calcific tendinitis


subject: PUBCHEM.COMPOUND:6433115

subject_name: reparixin

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:6433115

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:6433115

object_name: breast cancer


subject: UMLS:C1706764

subject_name: Uroxatrol

object_name: prostate carcinoma


subject: UMLS:C1706764

object_name: prostate cancer


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: CHEMBL.COMPOUND:CHEMBL4650415

object_name: intracerebral hemorrhage


subject: UMLS:C5544808


subject: PR:000002327

subject_name: gelsolin isoform 1

object_name: Febrile Neutropenia


subject: PR:000002327

object_name: Febrile Neutropenia, CTCAE


subject: GTOPDB:13396

subject_name: ivonescimab

object_name: colon carcinoma


subject: GTOPDB:13396

object_name: colorectal cancer


subject: GTOPDB:13396

object_name: colon cancer


subject: UNII:Y0O332CU66

subject_name: IVONESCIMAB


subject: UNII:Y0O332CU66


subject: UNII:Y0O332CU66


subject: UMLS:C5669600

subject_name: Ivonescimab


subject: UMLS:C5669600


subject: UMLS:C4508915

object_name: Solid Neoplasm


subject: UMLS:C0354604

subject_name: oral anticoagulants

object_name: Hemorrhage


subject: UMLS:C0354604

object_name: stroke disorder


subject: UMLS:C0354604

object_name: cerebrovascular disorder


subject: UMLS:C0354604

object_name: Stroke (heart beat)


subject: UMLS:C0354604

object_name: Stroke, CTCAE


subject: CHEBI:38940

subject_name: Sunitinib

object_name: hypertension


subject: CHEBI:38940

object_name: Hypertension, CTCAE


subject: CHEBI:38940

object_name: Sodium imbalance


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: thalassemia


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: Developmental Psychomotor Disorders


subject: PUBCHEM.COMPOUND:92043599

object_name: Intracranial Hemorrhage, CTCAE


subject: PUBCHEM.COMPOUND:92043599

object_name: Intracranial hemorrhage


subject: UMLS:C0376541

subject_name: Recombinant Erythropoietin


subject: UMLS:C0376541

object_name: Periventricular Leukomalacia, AE


subject: UMLS:C0376541


subject: UMLS:C0376541


subject: MESH:D057947

subject_name: Parenteral Nutrition Solutions

object_name: malnutrition


subject: MESH:D057947

object_name: Stomach cancer


subject: MESH:D057947

object_name: gastric cancer


subject: UNII:VYR5R5XN5A

subject_name: LUNSEKIMIG

object_name: chronic obstructive pulmonary disease


subject: UMLS:C5909039

subject_name: Lunsekimig


subject: CHEBI:68554

subject_name: Deferiprone


subject: UMLS:C4687517

object_name: Childhood Malignant Solid Neoplasm


subject: UMLS:C4687517

object_name: Malignant Solid Neoplasm


subject: UMLS:C5907926

subject_name: DNA Polymerase Theta Inhibitor ART6043

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C5907926

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C0001645

subject_name: Adrenergic beta-Antagonists

object_name: anterolateral myocardial infarction


subject: UMLS:C0001645

object_name: acute myocardial infarction


subject: UMLS:C1709935

subject_name: Rexin G


subject: UMLS:C1709935

object_name: cytokine release syndrome


subject: UMLS:C1709935

object_name: Cytokine storm


subject: UMLS:C1709935

object_name: acute respiratory distress syndrome


subject: UMLS:C1709935

object_name: adult acute respiratory distress syndrome


subject: CHEBI:3181

subject_name: Bromocriptine

object_name: type 1 diabetes mellitus


subject: PUBCHEM.COMPOUND:133082063

subject_name: Apitoxin

object_name: aphthous stomatitis


subject: UMLS:C0003574


subject: CHEBI:75922

subject_name: Nepafenac

object_name: congenital hereditary endothelial dystrophy of cornea


subject: UMLS:C4287779

subject_name: anti-OX40 antibody BMS 986178

object_name: B-cell non-Hodgkin lymphoma


subject: UMLS:C4287779

object_name: B-cell neoplasm


subject: UMLS:C4287779

object_name: mantle cell lymphoma


subject: UMLS:C4287779

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C4287779

object_name: marginal zone lymphoma


subject: UMLS:C4287779

object_name: MALT lymphoma


subject: UMLS:C4287779

object_name: lymphoplasmacytic lymphoma


subject: UMLS:C4287779

object_name: Waldenstrom macroglobulinemia


subject: UMLS:C4287779

object_name: Lymphoma, Small Cleaved-Cell, Follicular


subject: UMLS:C4287779

object_name: Lymphoma, Mixed-Cell, Follicular


subject: UMLS:C4287779

object_name: grade 3A follicular lymphoma


subject: UMLS:C2348637

subject_name: TLR9 Agonist SD-101


subject: UMLS:C2348637


subject: UMLS:C2348637


subject: UMLS:C2348637


subject: UMLS:C2348637


subject: CHEBI:49140

object_name: Recurrent ovarian cancer


subject: CHEBI:49140

object_name: Recurrent Ovarian Germ Cell Tumor


subject: CHEBI:49140

object_name: peritoneum cancer


subject: CHEBI:49140

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:49140

object_name: Ovarian cancer stage IV


subject: CHEBI:49140

object_name: Ovarian germ cell cancer stage IV


subject: CHEBI:49140

object_name: Stage IV Ovarian Germ Cell Tumor AJCC v6 and v7


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:188851

subject_name: Muraglitazar

object_name: diabetes mellitus


subject: UMLS:C1568490

subject_name: muraglitazar


subject: UMLS:C1176021

object_name: Carcinoma breast stage IV


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Pancreatic carcinoma non-resectable


subject: PUBCHEM.COMPOUND:2767

object_name: Recurrent Cancer of Gallbladder


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IV Gallbladder Cancer AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IV Gallbladder Cancer AJCC v6


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:4672

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:4672

object_name: stage IV pancreatic cancer


subject: CHEBI:4672

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:4672

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:4672

object_name: Pancreatic carcinoma stage III


subject: CHEBI:4672

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672

object_name: Unresectable Gallbladder Carcinoma


subject: CHEBI:4672

object_name: Stage IIIB Gallbladder Cancer AJCC v8


subject: CHEBI:4672

object_name: Stage IIIB Gallbladder Cancer AJCC v7


subject: CHEBI:4672

object_name: stage IIIA gallbladder cancer


subject: CHEBI:4672

object_name: Stage IIIA Gallbladder Cancer AJCC v7


subject: CHEBI:4672

object_name: Stage IIIA Gallbladder Cancer AJCC v8


subject: CHEBI:4672

object_name: Cholangiocarcinoma non-resectable


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Recurrent Cancer of Gallbladder


subject: CHEBI:175901

object_name: Stage IV Gallbladder Cancer AJCC v7


subject: CHEBI:175901

object_name: Stage IV Gallbladder Cancer AJCC v6


subject: UMLS:C3640822

object_name: Pancreatic adenocarcinoma metastatic


subject: UMLS:C3640822

object_name: pancreatic adenocarcinoma


subject: UMLS:C3640822

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C3640822

object_name: stage IV pancreatic cancer


subject: UMLS:C3640822

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UMLS:C3640822

object_name: Stage III Pancreatic Cancer AJCC v8


subject: UMLS:C3640822

object_name: Pancreatic carcinoma stage III


subject: UMLS:C3640822

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C3640822

object_name: Pancreatic carcinoma non-resectable


subject: UMLS:C3640822

object_name: head and neck squamous cell carcinoma


subject: UMLS:C3640822

object_name: Non-small cell lung cancer recurrent


subject: UMLS:C3640822

object_name: Non-small cell lung cancer stage IIIB


subject: UMLS:C3640822

object_name: Non-small cell lung cancer stage IIIA


subject: UMLS:C3640822

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C3640822

object_name: Recurrent Cancer of Gallbladder


subject: UMLS:C3640822

object_name: Unresectable Gallbladder Carcinoma


subject: UMLS:C3640822

object_name: Stage IIIB Gallbladder Cancer AJCC v8


subject: UMLS:C3640822

object_name: Stage IIIB Gallbladder Cancer AJCC v7


subject: UMLS:C3640822

object_name: stage IIIA gallbladder cancer


subject: UMLS:C3640822

object_name: Stage IIIA Gallbladder Cancer AJCC v7


subject: UMLS:C3640822

object_name: Stage IIIA Gallbladder Cancer AJCC v8


subject: UMLS:C3640822

object_name: Cholangiocarcinoma non-resectable


subject: UMLS:C3640822

object_name: Stage IV Gallbladder Cancer AJCC v7


subject: UMLS:C3640822

object_name: Stage IV Gallbladder Cancer AJCC v8


subject: UMLS:C3640822

object_name: Stage IV Gallbladder Cancer AJCC v6


subject: UMLS:C3489715

subject_name: indigo naturalis ointment

object_name: psoriasis


subject: UNII:NF3P9Z8J5Y

subject_name: baxdrostat

object_name: heart failure


subject: UNII:NF3P9Z8J5Y

object_name: Heart Failure, CTCAE


subject: DRUGBANK:DB19090

subject_name: Baxdrostat


subject: DRUGBANK:DB19090


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab

object_name: Mesothelioma


subject: UNII:QEN1X95CIX

object_name: mesothelial neoplasm


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: CHEBI:71954

subject_name: Buparlisib

object_name: Progressive cGVHD


subject: CHEBI:71954

object_name: Progressive Disease


subject: CHEBI:71954

object_name: Progressive Neoplastic Disease


subject: CHEBI:71954

object_name: IMWG Progressive Disease


subject: CHEBI:71954

object_name: irPD (Immune-Related Response Criteria)


subject: CHEBI:71954

object_name: Global Progressive Disease in Viscera


subject: CHEBI:71954

object_name: RECIL PD


subject: CHEBI:71954

object_name: Global Progressive Disease in Skin


subject: CHEBI:71954

object_name: Global Progressive Disease


subject: CHEBI:71954

object_name: Global Progressive Disease in Lymph Nodes


subject: CHEBI:71954

object_name: Global Progressive Disease in Blood


subject: CHEBI:71954

object_name: head and neck neoplasm


subject: CHEBI:71954

object_name: Recurrent disease


subject: CHEBI:151315

subject_name: Heparin

object_name: Aortic stenosis, non-rheumatic


subject: KEGG.COMPOUND:C00374


subject: CHEBI:41139

subject_name: BETAINE

object_name: Genotype 1


subject: CHEBI:41139

object_name: hepatitis C


subject: CHEBI:41139

object_name: chronic hepatitis C virus infection


subject: CHEBI:41139


subject: CHEBI:41139

object_name: Global Relapse in Viscera


subject: CHEBI:41139

object_name: Global Relapse in Lymph Nodes


subject: CHEBI:41139

object_name: Relapse Following Intervention for Kawasaki Disease


subject: CHEBI:41139

object_name: Global Relapse


subject: CHEBI:41139

object_name: Global Relapse in Skin


subject: CHEBI:41139

object_name: Global Relapse in Blood


subject: CHEBI:94463


subject: CHEBI:94463


subject: CHEBI:94463


subject: CHEBI:94463


subject: CHEBI:94463


subject: CHEBI:94463


subject: CHEBI:94463


subject: CHEBI:94463


subject: CHEBI:63580

subject_name: Ribavirin


subject: CHEBI:63580


subject: CHEBI:63580


subject: CHEBI:63580


subject: CHEBI:63580


subject: CHEBI:63580


subject: CHEBI:63580


subject: CHEBI:63580


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: systemic sclerosis


subject: UNII:3A189DH42V

object_name: diffuse scleroderma


subject: UNII:3A189DH42V

object_name: interstitial lung disease


subject: UNII:3A189DH42V

object_name: pulmonary hypertension


subject: UNII:3A189DH42V

object_name: Pulmonary Hypertension, CTCAE


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin


subject: UMLS:C0003442


subject: UMLS:C0003442


subject: UMLS:C0003442


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: GTOPDB:4942

subject_name: GM-CSF


subject: GTOPDB:4942


subject: GTOPDB:4942


subject: GTOPDB:4942


subject: GTOPDB:4942


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous


subject: UMLS:C0085297


subject: UMLS:C0085297


subject: UMLS:C0085297


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:9570

subject_name: Thiotepa


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: T-Cell Lymphoma


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: UMLS:C4547381

object_name: vulvovaginal candidiasis


subject: CHEBI:90881

subject_name: Camptosar

object_name: pediatric osteosarcoma


subject: CHEBI:90881

object_name: Osteosarcoma


subject: CHEBI:49668

subject_name: Gefitinib

object_name: rhabdomyosarcoma


subject: CHEBI:49668


subject: CHEBI:49668


subject: CHEBI:49668

object_name: Childhood Neuroblastoma


subject: CHEBI:49668

object_name: neuroblastoma


subject: CHEBI:233408

subject_name: Olesoxime

object_name: spinal muscular atrophy


subject: UMLS:C1170437

subject_name: Normal Saline Flush

object_name: sign or symptom


subject: CHEBI:185135

subject_name: Polyvidone


subject: CHEBI:8347

subject_name: Povidone-iodine


subject: PUBCHEM.COMPOUND:3084345

subject_name: Sodium aescinate

object_name: stroke disorder


subject: PUBCHEM.COMPOUND:3084345

object_name: cerebral infarction


subject: PUBCHEM.COMPOUND:3084345

object_name: cerebrovascular disorder


subject: MESH:C584713

subject_name: sodium aescinate


subject: MESH:C584713


subject: MESH:C584713


subject: CHEBI:17026

subject_name: Progesterone

object_name: urolithiasis


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: CHEBI:173923

subject_name: Isomyristicin


subject: CHEBI:8481

subject_name: Propantheline


subject: CHEBI:7565

subject_name: Nifedipine


subject: CHEBI:16865

subject_name: Aminobutyrates

object_name: diabetes mellitus


subject: UMLS:C0016904

subject_name: gamma-aminobutyric acid


subject: PUBCHEM.COMPOUND:57389748

subject_name: Linagliptin

object_name: vascular inflammations


subject: UMLS:C4476483

subject_name: DiaResQ Children's Powder for Suspension

object_name: diarrhea


subject: UMLS:C4476483

object_name: rectal discharge diarrhea (physical finding)


subject: UMLS:C4476483

object_name: Diarrhea, CTCAE


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: Fetal blood loss


subject: CHEBI:10033

subject_name: Warfarin


subject: CHEBI:17045

subject_name: Nitrous oxide

object_name: neuralgia


subject: CHEBI:17045

object_name: Neuropathic pain


subject: CHEBI:132889

subject_name: graphene oxide

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C0305364

subject_name: Ayr Saline Nasal Mist

object_name: Nasal congestion


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog


subject: CHEBI:7465

subject_name: Naltrexone

object_name: multiple sclerosis


subject: UNII:2GOW9TT6AD

subject_name: Udonitrectag

object_name: neurotrophic keratopathy


subject: CHEBI:63610

subject_name: Misoprostol

object_name: Stenosis of cervix


subject: UMLS:C5392069

subject_name: CTLA-4 Inhibitors

object_name: rectal carcinoma


subject: UMLS:C5392069

object_name: rectal cancer


subject: UMLS:C5392069

object_name: Childhood Rectal Carcinoma


subject: UMLS:C3644171

subject_name: tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed

object_name: Pregnant


subject: UMLS:C3644171

object_name: HIV-1 infection


subject: UMLS:C3644171

object_name: Infection following immunization


subject: UMLS:C3526553

subject_name: diphtheria, tetanus toxoids and acellular pertussis vaccine


subject: UMLS:C3526553


subject: UMLS:C3526553


subject: CHEBI:95165

object_name: autoimmune thrombocytopenia


subject: CHEBI:95165

object_name: thrombocytopenia due to immune destruction


subject: CHEBI:95165

object_name: autoimmune thrombocytopenic purpura


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:50131


subject: UMLS:C0962969

subject_name: RAD 001

object_name: acute lymphoblastic leukemia


subject: UNII:621XR2W6OP

subject_name: Methylprednisone

object_name: leukemia


subject: UNII:621XR2W6OP

object_name: childhood leukemia


subject: PUBCHEM.COMPOUND:5126752


subject: PUBCHEM.COMPOUND:5126752


subject: CHEBI:135573

subject_name: Meprednisone


subject: CHEBI:135573


subject: UMLS:C3495434

subject_name: hydroxyethyl starch 130-0.4

object_name: Drug-induced hypotension


subject: CHEBI:67900

subject_name: Salvinorin A

object_name: Drug action (disorder)


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: humoral hypercalcemia of malignancy


subject: UNII:4EQZ6YO2HI

object_name: tumor of parathyroid gland


subject: UNII:4EQZ6YO2HI

object_name: Neck Carcinoma


subject: UNII:4EQZ6YO2HI

object_name: head and neck neoplasm


subject: UNII:4EQZ6YO2HI

object_name: head and neck cancer


subject: UNII:4EQZ6YO2HI

object_name: non-Hodgkin lymphoma


subject: UNII:4EQZ6YO2HI

object_name: malignant endocrine neoplasm


subject: UNII:4EQZ6YO2HI

object_name: Carcinoma of Endocrine Gland


subject: UNII:4EQZ6YO2HI

object_name: Hodgkin Disease


subject: UNII:4EQZ6YO2HI

object_name: Disseminated Malignant Neoplasm


subject: UNII:4EQZ6YO2HI

object_name: thyroid tumor


subject: UNII:4EQZ6YO2HI

object_name: thyroid gland carcinoma


subject: UNII:4EQZ6YO2HI

object_name: thyroid cancer


subject: UNII:4EQZ6YO2HI

object_name: renal carcinoma


subject: UNII:4EQZ6YO2HI

object_name: kidney neoplasm


subject: UNII:4EQZ6YO2HI

object_name: kidney cancer


subject: UNII:4EQZ6YO2HI

object_name: colon carcinoma


subject: UNII:4EQZ6YO2HI

object_name: colon cancer


subject: UNII:4EQZ6YO2HI

object_name: adult lymphoma


subject: UNII:4EQZ6YO2HI

object_name: lymphoma


subject: UNII:4EQZ6YO2HI

object_name: pediatric lymphoma


subject: UMLS:C1530450

subject_name: AMG 162

object_name: humoral hypercalcemia of malignancy


subject: UMLS:C1530450

object_name: tumor of parathyroid gland


subject: UMLS:C1530450

object_name: Neck Carcinoma


subject: UMLS:C1530450

object_name: head and neck neoplasm


subject: UMLS:C1530450

object_name: head and neck cancer


subject: UMLS:C1530450

object_name: non-Hodgkin lymphoma


subject: UMLS:C1530450

object_name: malignant endocrine neoplasm


subject: UMLS:C1530450

object_name: Carcinoma of Endocrine Gland


subject: UMLS:C1530450

object_name: Hodgkin Disease


subject: UMLS:C1530450

object_name: thyroid tumor


subject: UMLS:C1530450

object_name: thyroid gland carcinoma


subject: UMLS:C1530450

object_name: thyroid cancer


subject: UMLS:C1530450

object_name: renal carcinoma


subject: UMLS:C1530450

object_name: kidney neoplasm


subject: UMLS:C1530450

object_name: kidney cancer


subject: UMLS:C1530450

object_name: colon carcinoma


subject: UMLS:C1530450

object_name: colon cancer


subject: UMLS:C1530450

object_name: adult lymphoma


subject: UMLS:C1530450

object_name: lymphoma


subject: UMLS:C1530450

object_name: pediatric lymphoma


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: type 2 diabetes mellitus


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: Colorectal cancer recurrent


subject: GTOPDB:9758

subject_name: camrelizumab


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: CHEBI:30145

subject_name: lithium atom

object_name: spinal cord injury


subject: UNII:L2N7Z24B30

subject_name: lithium orotate


subject: CHEBI:49713

subject_name: Lithium cation


subject: UMLS:C3540800

subject_name: Lithium antipsychotics


subject: UMLS:C5201249

subject_name: CXCR4 INHIBITOR X4P-001

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5201249

object_name: clear cell renal carcinoma


subject: GTOPDB:6803

subject_name: dalteparin

object_name: brain neoplasm


subject: UNII:PUE0TO3XDR

subject_name: Dalteparin


subject: UMLS:C4085978

subject_name: Anti-pd-1 checkpoint inhibitor pf-06801591


subject: UMLS:C4085978


subject: UMLS:C4085978

object_name: renal cell adenocarcinoma


subject: UMLS:C4085978

object_name: renal cell carcinoma


subject: UMLS:C4085978

object_name: squamous cell lung carcinoma


subject: UMLS:C4085978

object_name: endometrial cancer


subject: UMLS:C4085978

object_name: uterine corpus cancer


subject: UMLS:C4085978

object_name: endometrial carcinoma


subject: UMLS:C4085978

object_name: carcinoma of esophagus


subject: UMLS:C4085978

object_name: esophageal cancer


subject: UMLS:C4085978

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C4085978

object_name: neoplasm of esophagus


subject: UMLS:C4085978

object_name: pancreatic neoplasm


subject: UMLS:C4085978

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4085978

object_name: malignant pancreatic neoplasm


subject: UMLS:C4085978

object_name: Stomach cancer


subject: UMLS:C4085978

object_name: gastric cancer


subject: UMLS:C4085978

object_name: ovarian cancer


subject: UMLS:C4085978

object_name: ovarian neoplasm


subject: UMLS:C4085978

object_name: ovarian carcinoma


subject: UMLS:C4085978

object_name: bile duct carcinoma


subject: UMLS:C4085978

object_name: bile duct cancer


subject: UMLS:C4085978

object_name: cholangiocarcinoma


subject: UMLS:C5417889

subject_name: Alpha V Beta 8 Antagonist PF-06940434

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5417889

object_name: clear cell renal carcinoma


subject: UMLS:C5417889

object_name: renal cell adenocarcinoma


subject: UMLS:C5417889

object_name: renal cell carcinoma


subject: UMLS:C5417889

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5417889

object_name: squamous cell lung carcinoma


subject: UMLS:C5417889

object_name: endometrial cancer


subject: UMLS:C5417889

object_name: uterine corpus cancer


subject: UMLS:C5417889

object_name: endometrial carcinoma


subject: UMLS:C5417889

object_name: carcinoma of esophagus


subject: UMLS:C5417889

object_name: esophageal cancer


subject: UMLS:C5417889

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C5417889

object_name: neoplasm of esophagus


subject: UMLS:C5417889

object_name: pancreatic neoplasm


subject: UMLS:C5417889

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5417889

object_name: malignant pancreatic neoplasm


subject: UMLS:C5417889

object_name: Stomach cancer


subject: UMLS:C5417889

object_name: gastric cancer


subject: UMLS:C5417889

object_name: ovarian cancer


subject: UMLS:C5417889

object_name: ovarian neoplasm


subject: UMLS:C5417889

object_name: ovarian carcinoma


subject: UMLS:C5417889

object_name: bile duct carcinoma


subject: UMLS:C5417889

object_name: bile duct cancer


subject: UMLS:C5417889

object_name: cholangiocarcinoma


subject: UMLS:C3850610

object_name: Crohn disease


subject: PUBCHEM.COMPOUND:45382195

subject_name: Thymosin Beta 4

object_name: Varicose Ulcer


subject: UMLS:C0076616

subject_name: Thymosin beta-4


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Dermatitis, Actinic


subject: CHEBI:8404

subject_name: Prilocaine


subject: UNII:JH6Z94GLUD

object_name: Myelodysplasia


subject: UNII:JH6Z94GLUD

object_name: acute myeloid leukemia


subject: CHEBI:8249

subject_name: Piroxicam

object_name: Impacted third molar tooth


subject: CHEBI:8249

object_name: Complication of other surgical procedures


subject: UNII:85KUE857XM

subject_name: SHR-1258 dimaleate

object_name: Childhood Breast Carcinoma


subject: UNII:85KUE857XM

object_name: breast carcinoma


subject: UNII:85KUE857XM

object_name: breast cancer


subject: UMLS:C5206643

subject_name: Pyrotinib Dimaleate


subject: UMLS:C5206643


subject: UMLS:C5206643


subject: UNII:1WPE73O1WV

subject_name: PRALSETINIB

object_name: medullary thyroid gland carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4582651

subject_name: Pralsetinib


subject: UMLS:C5556479

subject_name: Toll-like Receptor 7/8 Agonist BDB018

object_name: Childhood Solid Neoplasm


subject: UMLS:C5556479

object_name: Adult Solid Neoplasm


subject: UMLS:C5556479

object_name: Solid Neoplasm


subject: UMLS:C5417861

subject_name: Plasmid DNA Vaccine pING-hHER3FL

object_name: Advanced cancer


subject: CHEBI:17154

subject_name: Nicotinamide

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:71219

subject_name: Pazopanib


subject: CHEBI:17688

subject_name: Nicotine

object_name: change; retina


subject: CHEBI:173082

subject_name: sialic acid

object_name: GNE myopathy


subject: CHEBI:173082

object_name: myopathy, distal, with rimmed vacuoles


subject: UMLS:C0699857

subject_name: Nitrate

object_name: gingivitis


subject: UMLS:C0699857

object_name: periodontitis


subject: CHEBI:17632


subject: CHEBI:17632


subject: CHEBI:48107

subject_name: Nitric acid


subject: CHEBI:48107


subject: UMLS:C3852764

subject_name: PEG-rhG-CSF

object_name: carcinoma of esophagus


subject: UMLS:C3852764

object_name: esophageal cancer


subject: UMLS:C3852764

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C3852764

object_name: neoplasm of esophagus


subject: CHEBI:33364

subject_name: Platinum


subject: CHEBI:33364


subject: CHEBI:33364


subject: CHEBI:33364


subject: CHEMBL.COMPOUND:CHEMBL1235478

subject_name: PLATINUM


subject: CHEMBL.COMPOUND:CHEMBL1235478


subject: CHEMBL.COMPOUND:CHEMBL1235478


subject: CHEMBL.COMPOUND:CHEMBL1235478


subject: UMLS:C1171558

subject_name: Platinum metallicum, platinum, Homeopathic preparation


subject: UMLS:C1171558


subject: UMLS:C1171558


subject: UMLS:C1171558


subject: PUBCHEM.COMPOUND:134506

subject_name: Dehydroandrosterone

object_name: Menopausal syndrome


subject: PUBCHEM.COMPOUND:134506

object_name: Libido disorder


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:63613

subject_name: Nevirapine

object_name: hepatitis C


subject: CHEBI:37670

subject_name: protease inhibitor


subject: UMLS:C0033607

subject_name: Protease Inhibitors


subject: UMLS:C3540755

subject_name: Protease inhibitors, direct acting antivirals


subject: UMLS:C5446554

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5446554

object_name: pleural mesothelioma


subject: UMLS:C5446554

object_name: malignant pleural mesothelioma


subject: UMLS:C5446554

object_name: liver cancer


subject: UMLS:C5446554

object_name: liver neoplasm


subject: UMLS:C5446554

object_name: Adult Liver Carcinoma


subject: UMLS:C5446554

object_name: lung cancer


subject: UMLS:C5446554

object_name: lung neoplasm


subject: UMLS:C5446554

object_name: lung carcinoma


subject: UMLS:C5446554

object_name: adult lymphoma


subject: UMLS:C5446554

object_name: lymphoma


subject: UMLS:C5446554

object_name: pediatric lymphoma


subject: CHEBI:172944

subject_name: Cabotegravir

object_name: AIDS


subject: UMLS:C5417967

subject_name: AR Inhibitor EPI-7386

object_name: prostate neoplasm


subject: UMLS:C1741942

subject_name: Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)

object_name: juvenile idiopathic arthritis


subject: CHEBI:4975

subject_name: Famotidine

object_name: EXCESS LMW-DNA


subject: CHEBI:4975

object_name: lupus vulgaris


subject: CHEBI:4975

object_name: lupus erythematosus


subject: CHEBI:4975

object_name: discoid lupus erythematosus


subject: CHEBI:73629

subject_name: Phe-Asp-Cys

object_name: pulmonary hypertension


subject: CHEBI:38848

subject_name: perflunafene


subject: PR:000001881

subject_name: lymphocyte activation gene 3 protein


subject: CHEBI:309594

subject_name: Oxybuprocaine

object_name: Ocular surface disease


subject: CHEBI:309594

object_name: Ocular Surface Disease, CTCAE


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Refractory Brain Neoplasm


subject: CHEBI:4026

object_name: Recurrent Brain Neoplasm


subject: CHEBI:4026

object_name: Recurrent Medulloblastoma


subject: CHEBI:4026

object_name: medulloblastoma non-WNT/non-SHH


subject: CHEBI:4026

object_name: Malignant neoplasm of the central nervous system


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: UNII:820NH671E6

subject_name: Prexasertib

object_name: brain neoplasm


subject: UNII:820NH671E6

object_name: medulloblastoma


subject: UNII:820NH671E6

object_name: childhood medulloblastoma


subject: UNII:820NH671E6

object_name: adult medulloblastoma


subject: UNII:820NH671E6


subject: UNII:820NH671E6


subject: UNII:820NH671E6


subject: UNII:820NH671E6


subject: UNII:820NH671E6

object_name: brain cancer


subject: UNII:820NH671E6

object_name: medulloblastoma non-WNT/non-SHH group 4


subject: UNII:820NH671E6

object_name: medulloblastoma non-WNT/non-SHH group 3


subject: UNII:820NH671E6

object_name: Childhood Brain Neoplasm


subject: UNII:820NH671E6

object_name: central nervous system neoplasm


subject: UNII:820NH671E6

object_name: central nervous system cancer


subject: UNII:820NH671E6


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: CHEBI:59527

object_name: Dysmenorrhea, CTCAE


subject: CHEBI:59527

object_name: Dysmenorrhea


subject: CHEBI:91939

subject_name: (R)-Naproxen


subject: CHEBI:91939


subject: HMDB:HMDB0001349

subject_name: Selenium

object_name: obstructive lung disease


subject: HMDB:HMDB0001349

object_name: lung disorder


subject: UMLS:C0521939

subject_name: Selenium supplement


subject: UMLS:C0521939


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class


subject: UMLS:C3714803


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: UNII:47RRR83SK7

subject_name: [OBSOLETE] interferon alfa-2a

object_name: end stage renal failure


subject: UNII:47RRR83SK7

object_name: Chronic uremia